- Investing Ideas
- U.K. Healthcare Undervalued over 20% based on DCF
U.K. Healthcare Undervalued over 20% based on DCF
Results
5
Companies which are undervalued more than 20% based on the Discounted Cash Flow valuation.
5 companies
Smith & Nephew
Market Cap: UK£9.8b
Develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally.
SN.
UK£11.61
7D
4.7%
1Y
3.6%
CVS Group
Market Cap: UK£865.0m
Engages in veterinary, online pharmacy, and retail businesses in the United Kingdom and Australia.
CVSG
UK£12.38
7D
0.4%
1Y
-3.7%
NIOX Group
Market Cap: UK£254.9m
Engages in the design, development, and commercialization of medical devices for the diagnosis, monitoring, and management of asthma and COPD worldwide.
NIOX
UK£0.58
7D
-4.6%
1Y
-15.2%
EKF Diagnostics Holdings
Market Cap: UK£109.3m
Engages in the design, development, manufacture, and sale of diagnostic instruments, reagents, and other ancillary products in the Americas, Europe, the Middle East, Asia, Africa, and internationally.
EKF
UK£0.25
7D
-6.1%
1Y
-5.3%
EMV Capital
Market Cap: UK£13.6m
A venture capital firm specializing in seed, growth capital, early and mid stage investments.
EMVC
UK£0.48
7D
0%
1Y
4.3%